Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH(TM) (Cantharidin) Topical Solution for the Treatment of Molluscum on October 11, 2023

Source :: GlobeNewswire. September 27, 2023
Publication Year :: 2023
Abstract: WEST CHESTER, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ('Verrica' or 'the Company') (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, [...]

Subjects :: Skin diseases -- Care and treatment
Pediatric dermatology
Children -- Health aspects
Drug approval
Skin
Banking, finance and accounting industries
Business
American Academy of Dermatology
Ycanth (Medication)

Tools